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Abstract: The aim of the present study was to investigate the gastroprotective activity  
of a sulfated-polysaccharide  (PLS)  fraction  extracted from the marine red algae   
Gracilaria caudata  and the mechanism underlying the gastroprotective activity. Male 
Swiss mice were treated with PLS (3, 10, 30 and 90 mg·kg
−1, p.o.), and after 30 min, they 
were administered 50% ethanol (0.5 mL/25 g
−1, p.o.). One hour later, gastric damage was 
measured using a planimeter. Samples of the stomach tissue were also obtained for 
histopathological assessment and for assays of glutathione (GSH) and malondialdehyde 
(MDA). Other groups were pretreated with L-NAME (10 mg·kg
−1, i.p.), DL-propargylglycine 
OPEN ACCESS Mar. Drugs 2011, 9  2189 
 
(PAG, 50 mg·kg
−1, p.o.) or glibenclamide (5 mg·kg
−1, i.p.). After 1 h, PLS (30 mg·kg
−1, p.o.) 
was administered. After 30 min, ethanol 50% was administered (0.5 mL/25g
−1,  p.o.), 
followed by sacrifice after 60 min. PLS prevented-ethanol-induced macroscopic and 
microscopic gastric injury in a dose-dependent manner. However, treatment with L-NAME 
or glibenclamide reversed this gastroprotective effect. Administration of propargylglycine 
did not influence the effect of PLS. Our results suggest that PLS has a protective effect 
against ethanol-induced gastric damage in mice via activation of the NO/KATP pathway. 
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1. Introduction 
Marine organisms are sources of numerous new compounds with multiple pharmacological 
properties [1]. At present, the number of substances being isolated from such sources is growing. Most 
of their chemical structures have been elucidated, and they are being investigated for their potential to 
meet various biological objectives, as well as to expand the scientific knowledge base in the area of 
naturally bioactive compounds [2]. Currently, about 25–30% of all active agents used in treatments are 
extracted from natural products [3]. In the last 50 years, sulfated-polysaccharide has drawn the 
attention of researchers, since it has become clear that it is involved in several cellular processes [4] 
and therefore, may present many pharmacological opportunities [5–8]. 
In algae, these sulfated-polysaccharides are complex macromolecular constituents of the extracellular 
matrix, and they evidently play an important role in the mechanical, osmotic, and ionic regulation of 
these beings [9,10]. Investigation of these biomolecules has been steadily increasing in recent years 
owing to their broad potential development as antithrombotic, anti-viral, anticoagulant, antioxidant, 
anti-inflammatory, and anti-proliferative agents [11–14]. However, studies of sulfated-polysaccharide 
extracted from sea algae (hereafter referred to as “PLS” throughout this manuscript) in ethanol-induced 
gastric damage models are scarce. 
In the gastrointestinal tract, ethanol can produce acute hemorrhagic gastric damage, and excessive 
ingestion can result in gastritis characterized by mucosal edema, subepithelial hemorrhages, cellular 
exfoliation, and inflammatory cell infiltration [15,16]. Multiple mechanisms are likely to be involved 
in this pathogenic process, including depletion of non-protein sulfhydryl groups (thereby increasing 
reactive oxygen species (ROS) that have ulcerogenic activity), modulation of the nitric oxide system, 
and reduction of gastric mucosal blood flow. It has also been suggested that oxidative stress and 
depletion of anti-oxidants may be a crucial step in ethanol-induced mucosal damage [17]. In recent 
years, algal sulfated-polysaccharides have been demonstrated to play an important role as free-radical 
scavengers and antioxidants in the prevention of oxidative damage in living organisms [13,18].  
Nitric oxide (NO) and hydrogen sulfide (H2S) are crucial mediators of gastrointestinal mucosal 
defense [19–22]. Studies have demonstrated that these gases are responsible for the modulation of 
some general components of mucosal defense such as increase of the gastric mucosal blood flow, 
mucus and bicarbonate secretion, and inhibition of neutrophil adherence to endothelial cells [19,23–25]. 
Thus, considering that the sea algae are important sources of new chemical substances with potential Mar. Drugs 2011, 9  2190 
 
therapeutic effects, this study sought to evaluate the gastroprotective effect of a sulfated-polysaccharide 
fraction extracted from the sea algae Gracilaria caudata (PLS) against ethanol-induced gastric damage 
in mice, and the possible mechanisms involved. 
2. Results and Discussion 
Alcohol-related diseases of the gastrointestinal tract play an important role in clinical 
gastroenterology. However, the mechanisms and pathophysiology underlying the effects of ethanol on 
the organs of the digestive tract are not yet completely understood. The gastroprotective activity of 
PLS was evaluated using the ethanol-induced gastric damage model, the most commonly employed 
model in the evaluation of anti-ulcer/cytoprotective activity. Ethanol administration evidently resulted 
in severe macroscopic and microscopic gastric mucosal damage through an increase in reactive oxygen 
species generation and a decrease in the endogenous anti-oxidant defense mechanisms [26]. In the 
present study, we confirmed that ethanol induced gastrophathy (61.3 ± 18.9 mm
2) and that PLS 
treatment reduced the macroscopic and microscopic ethanol-induced gastric damage. Figure 1 shows 
that the PLS prevented ethanol-gastropathy in a dose-dependent manner, reaching maximal effect at a 
dose of 30 mg·kg
−1 (4.9 ± 3.7 mm
2). Because a PLS dose of 30 mg·kg
−1 afforded the most protection 
against gastric lesions induced by ethanol, this dose was selected for the study of the possible 
mechanisms of action involved in PLS-mediated gastroprotective effects. 
Figure 1. The effect of PLS on ethanol-induced gastric damage. Mice were treated by 
gavage with either saline or PLS (3, 10, 30 and 90·mg·kg
−1). Thirty minutes later, mice in 
experimental groups were administered 50% ethanol (0.5 mL/25 g
−1); the negative control 
group was administered saline. The total area of macroscopic gastric lesions was determined 
after 1 h. The results are expressed as mean ± SEM of a minimum of 5 animals per group.  
# p < 0.05 vs. saline group; * p < 0.05 vs. ethanol group; ANOVA and Newman-Keuls test. 
 
Figure 2 shows that ethanol administration induced a gastric superficial region disruption with 
epithelial cell loss and intense hemorrhage. Conversely, these afflictions were not observed in mice 
treated with ethanol and 30·mg·kg
−1 of PLS. These data suggest that PLS has a gastroprotective effect 
in this context.  Table 1 shows that PLS  treatment (30 mg·kg
−1) resulted in less ethanol-induced 
hemorrhagic damage, edema, and epithelial cell loss. Notably, these data indicate that ethanol did not Mar. Drugs 2011, 9  2191 
 
increase inflammatory cell infiltration in the gastric mucosa compared with controls; however, this is 
probably due to mice being sacrificed just 1 h after ethanol administration (Figure 2 and Table 1). 
Figure 2. Photomicrographs of gastric mucosa (Magnification, 100×): (A) saline control; 
(B) animals treated with 50% ethanol, showing disruption of the superficial region of the 
gastric gland with epithelial cell loss and intense hemorrhage; (C) animals treated with 
50% ethanol + polysaccharide (30 mg·kg
−1), showing preservation of the gastric mucosa. 
Quantitative results from these assessments are shown in Table 1. 
 
Table 1. The effect of PLS (30 mg·kg
−1) on ethanol-induced microscopic gastric damage. 
Experimental group  














Saline   0  0 (0–1)  0  0  0 
Ethanol  3 (3–4)  3 (3–4)  2 (2–3)  0 (0–1)  8 (6–10) 
Ethanol + PLS 30 mg·kg
−1  1 (0–2) *  1 (0–1) *  1 (0–1) *  0  3 (0–3) * 
Data shown are medians with minimal and maximal scores shown in parentheses. The   
Kruskal-Wallis nonparametric test, followed by Dunn’s test was used for multiple comparisons of 
histological analyses. * p < 0.05 vs. control (ethanol) group. 
It has been suggested that oxygen-derived free radicals (ROS) may contribute to ethanol-induced 
gastric mucosal lesions [27,28] and deplete the reduced glutathione  (GSH)  content in stomach   
tissues [21,27,29]. Our results are in accordance with these reports; ethanol induced a decrease in 
gastric GSH (298.3 ± 18.2 μg/g tissue) as compared to the saline group (415.0 ± 28.7 μg/g tissue) 
(Figure 3). Thus, PLS may function by decreasing the redox state in ethanol-induced gastropathy. Our 
results showed that administration of PLS (30 mg·kg
−1; 369.7 ± 19.4 μg/g tissue) reversed the decrease 
in the gastric GSH levels after ethanol administration. Therefore, we inferred that the protective effect 
of PLS administration might be explained by a resultant increase in the gastric GSH concentration. 
Another possibility is that an increase in GSH levels could be secondary to a decrease in the free 
radical production. Superoxide produced by peroxidase in the stomach tissues might damage cell 
membranes and cause ulcers by increasing malondialdehyde (MDA) level, the most widely used index 
of lipid peroxidation [30]. Our results suggest that administration of 30 mg·kg
−1 (20.0 ± 11.9 nmol·g
−1 Mar. Drugs 2011, 9  2192 
 
of tissue) of PLS resulted in a significant decrease in the MDA concentrations in ethanol-induced 
gastropathy  (115.1 ± 7.4 nmol·g
−1  of tissue) (Figure 4).  Several authors evaluated the effect of 
different gastroprotective and antioxidants  extracts, also had similar results [29–31].  Thus, the 
mechanism through which PLS exerts gastroprotective effects seems to involve an indirect antioxidant 
activities and a reduction of the lipid peroxidation induced by ethanol. 
Figure 3. The effect of PLS on glutathione (GSH) levels in the gastric mucosa of mice 
treated with ethanol. Mice were treated by gavage with saline or PLS (30 mg·kg
−1). Thirty 
minutes later, 50% ethanol (0.5 mL 25 g
−1) was administered to the experimental groups, 
while the control group was administered saline. Ethanol administration promoted a 
reduction in the GSH gastric levels. This effect was partially reverted when the animals 
were treated with PLS. The results are expressed as mean ± SEM of 5 animals per group.  
# p < 0.05 vs. saline group; * p < 0.05 vs. ethanol group; ANOVA and Newman-Keuls test. 
 
Figure 4.  The  effect of PLS on malondialdehyde  (MDA)  concentration in the gastric 
mucosa of mice treated with ethanol. Mice were treated by gavage with PLS (30 mg·kg
−1). 
Thirty minutes later, mice in the experimental group were administered 50% ethanol   
(0.5 mL 25 g
−1), and the control group was administered saline. The ethanol evidently 
promoted an increase in MDA gastric levels. When the animals were pre-treated with PLS, 
this effect was reverted. The results are expressed as the Means ± SEM of 5 animals per 
group. 
#  p  < 0.05 vs.  saline group; *  p  < 0.05 vs.  ethanol group; ANOVA and   
Newman-Keuls test. 
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Using a pharmacological approach it was demonstrated that PLS provides a protective effect against 
ethanol-induced gastric damage via the NO/KATP pathway. As shown in Figure 5, in animals treated 
with  L-NAME (74.9 ± 22.9 mm
2, a non selective inhibitor of nitric oxide synthase) or with 
glibenclamide (41.6 ± 6.5 mm
2, a drug that blocks KATP-dependent channels), the gastroprotective 
effect of PLS 30 mg·kg
−1 (12.5 ± 8.3 mm
2) was abrogated. This attests to the involvement of the 
NO/KATP pathway in the protection conferred by PLS. However, when the animals were pretreated 
with DL-propargylglycine (9.8 ± 3.5 mm
2, an H2S synthesis inhibitor that blocks CSE activity), it did 
not alter the protective effect of PLS.  
Figure 5. The effect of L-NAME, PAG, and glibenclamide on PLS-mediated protection 
against macroscopically visible ethanol-induced gastric damage. Mice were initially treated 
with  L-NAME (10 mg·kg
−1,  i.p.),  DL-propargylglycine (PAG, 50 mg·kg
−1,  p.o.), or 
glibenclamide (5 mg·kg
−1, i.p.). After 1 h, PLS (30 mg·kg
−1, p.o.) was administered. Thirty 
minutes later, 50% ethanol was administered to the experimental groups, and the control 
group was administered saline. The total area of the macroscopic gastric lesions was 
determined after 1 h. The results are expressed as mean ± SEM of a minimum of 5 animals 
per group. * p < 0.05 vs. ethanol group; 
# p < 0.05 vs. PLS + ethanol group; ANOVA and 
Newman-Keuls test. 
 
Nitric oxide (NO) modulates several elements of gastric mucosal defense, including blood flow [32], 
neutrophil adhesion [33,34], and mucus secretion [25,35]. NO and cyclic GMP can both activate 
various types of K
+ channels [36,37]. Recently, it was demonstrated that the activation of ATP-sensitive 
potassium channels (KATP) is involved in gastric defense [38,39]. Our findings suggest that the PLS 
defensive effect is a NO-dependent process and that blockage of the NO/KATP  pathway with   
L-NAME/glibenclamide abrogated the protective effect of PLS against ethanol-induced gastric damage. 
It has been demonstrated that the development of stress-induced gastric mucosal injury, including 
an increase in the gastric acid secretion, is involved in the pathogenesis of ethanol-induced gastric 
mucosal injury [40]. Several studies suggest that hypersecretion of gastric acid is associated with 
ethanol-induced gastric damage, and the anti-ulcer activity of many compounds may be related to the 
inhibition of gastric acid secretion [41,42]. However, in our study, PLS did not alter gastric acid 
secretion. As shown in Table 2, administration of PLS did not change the volume of gastric juice, the 
pH or the total acidity as compared to similarly derived values observed in the saline group.  In Mar. Drugs 2011, 9  2194 
 
contrast, histamine treatment increased the volume and total acidity, while ranitidine (an H2 
antagonist) decreased the volume and total acidity, as compared to corresponding values in the saline 
group (Table 2). 
Table 2. The effects of PLS on gastric secretion in 4-h pylorus-ligated mice. 
Experimental Group (n = 5)  Volume 
(μL) 
pH  Total Acid 
(mEq[H
+]/L/4 h) 
Saline  504 ± 39.2  1.6 ± 0.4  5.0 ± 0.3 
PLS (30 mg·kg
−1)   550 ± 89.1  1.8 ± 0.8  5.4 ± 0.6 
Histamine  993 ± 90.8 *  1.5 ± 0.5  10 ± 0.6 * 
Ranitidine  295 ± 78.3 
#  2.7 ± 0.5  2.4 ± 0.5 
# 
Data shown are expressed as mean ± SEM (n = 5). * p < 0.05; 
# p < 0.05, vs. saline group; ANOVA 
and Newman-Keuls test. 
In summary, our results indicate that PLS prevents ethanol-induced gastric damage. While there are 
many mechanisms through which this effect could potentially occur, our data supports the hypothesis 
that the reduction of lipid peroxidation and the activation of the NO/KATP pathway are of primary 
importance. These observations also raise the possibility of polysaccharides being used to improve 
resistance to gastric mucosal injury. 
3. Experimental Section 
3.1. Extraction of Soluble Polysaccharide 
Specimens of the red algae Gracilaria caudata were collected in August 2008 from the Atlantic 
coast northeast of Brazil (Fleixeira Beach, Trairi-Ceará). After collection, the algae were cleaned of 
epiphytes, washed with distilled water, and stored at −20  °C. In order to enable extraction of 
polysaccharide, 5 g of dried G. caudata tissue was ground into a fine powder and incubated in stirring 
distilled water (1.5% w/v) for 2 h at 100 °C. After filtration and concentration of the solution, the 
polysaccharide was precipitated with ethanol (1:3 v/v) followed by washing with acetone and dried 
with hot air flow. The polysaccharide fraction was then re-dissolved in distilled water (1.5% w/v) and 
subjected to the same process to achieve precipitation, washing, and drying. The polysaccharide 
fraction thus derived constitutes what is referred to throughout this manuscript as “PLS”. 
3.2. Animals 
Male Swiss mice (25–30 g) were fasted for 18 to 24 h before the experiments. Animals were housed 
in cages in temperature-controlled rooms, and food and water were available ad libitum. All animal 
treatments and surgical procedures were performed in accordance with the Guide for Care and Use of 
Laboratory Animals (National Institute of Health, Bethesda, MD, USA) and were approved by the 
appropriate ethics committee (protocol No. 0066/10). Mar. Drugs 2011, 9  2195 
 
3.3. The Effect of PLS on Ethanol-Induced Gastric Damage 
Male Swiss mice were initially treated with PLS (3, 10, 30 and 90 mg·kg
−1) by gavage. After 30 min, 
gastric damage was induced in the experimental groups by ethanol administration (0.5 mL/25 g
−1 p.o.), 
while the control group received saline. One hour later, the animals were sacrificed and their stomachs 
rapidly removed—opened via an incision along the greater curvature and pinned out on a wax block. 
Gastric damage (hemorrhagic or ulcerative lesions) was measured using a computer planimetry 
program (Image J
®). A sample of the corpus region of each stomach was fixed in 10% formalin 
immediately after removal for subsequent histopathological assessment. Further gastric corpus samples 
were then weighed, frozen, and stored at −70 °C until they were assayed for GSH [43] and MDA [44]. 
3.4. The Roles of NO and H2S in the Protective Effect of PLS 
Animals were pre-treated with a non-selective NO-synthase inhibitor, N-nitro-L-arginine methyl 
ester hydrochloride (L-NAME, 10 mg kg
−1, i.p.), or with DL-propargylglycine (PAG, 50 mg·kg
−1, p.o.), 
an inhibitor of H2S synthesis. After 1 h, the mice were administered PLS (30 mg·kg
−1 p.o.). Thirty 
minutes later, gastric damage was induced in the experimental mice by intragastric instillation of 
ethanol 50% (0.5 mL/25 g
−1 p.o.), while the control group received saline. One hour later, gastric 
damage was analyzed as described above.  
3.5. The Role of KATP in PLS-Mediated Gastric Protection 
To study the role of KATP  in PLS-mediated gastric protection, animals were pre-treated with 
glibenclamide (5 mg·kg
−1, i.p.), a drug that blocks KATP-dependent channels. After 1 h, the mice 
received PLS (30 mg·kg
−1 p.o.). Thirty minutes later, gastric damage was induced in experimental 
mice by intragastric instillation of ethanol 50% (0.5 mL/25 g
−1 p.o.), while the control group received 
saline. One hour later, gastric damage was determined as described above.  
3.6. Histological Assessment 
For histological assessment, stomach samples were fixed in 10% formalin solution, sectioned, and 
embedded in paraffin. Four-micrometer-thick sections were deparaffinized, stained with hematoxylin 
and eosin, and then examined under a microscope. The specimens were assessed according to the 
criteria described in Laine and Weinstein (1988) [45]. In brief, 1 cm lengths of each histological 
section were assessed for epithelial cell loss (a score of 0–3), edema in the upper mucosa (a score of 0–4), 
hemorrhagic damage (a score of 0–4) and the presence of inflammatory cells (a score of 0–3). 
Subsequently, the sections were assessed as “blind” (without knowledge of the prior treatments) by an 
experienced pathologist. 
3.7. GSH Assay 
The reduced GSH content of the stomach tissues was estimated according to the method described 
in Sedlak and Lindsay (1968) [43]. A segment from each stomach was homogenized in 5 mL of cold 
0.02 M EDTA solution (1 mL 100 mg
−1 tissue). Aliquots (400 μL) of tissue homogenate were mixed Mar. Drugs 2011, 9  2196 
 
with 320 μL  of distilled water and 80 μL  of 50% (w/v) trichloroacetic acid in glass tubes and 
centrifuged at 3000 rpm for 15 min. Next, 400 μL of each supernatant was mixed with 800 μL of Tris 
buffer (0.4 M, pH 8.9), and 20 μL of 0.01 M 5,5-dithio-bis (2-nitrobenzoic acid). After shaking the 
preparation, absorbance was measured at 412 nm on a spectrophotometer. GSH concentration was 
ascertained via a reduced GSH standard curve, generated in parallel. The results are expressed as 
micrograms of GSH per gram of tissue. 
3.8. MDA Assay 
The level of MDA in the homogenate from each group was measured using the method described in 
Mihara and Uchiyama (1978) [44], which is based on a thiobarbituric acid reaction. Fragments of the 
gastric mucosa weighing between 100 and 150 mg were homogenized with cold 1.15% KCl to prepare 
10% homogenates. In brief, 250 μL of each homogenate was added to 1.5 mL of 1% H3PO4 and 0.5 mL 
of 0.6% tert-butyl alcohol (aqueous solution). Then, this mixture was stirred and heated in a boiling 
water bath for 45 min. The preparation was then cooled immediately in an ice water bath, followed by 
the addition of 4 mL of n-butanol. This mixture was shaken and the butanol layer was separated by 
centrifugation at 1200 g for 10 min. Optical density was determined to be 535 and 520 nm, and the 
optical density difference between the 2 determinations was calculated as the tert-butyl alcohol value. 
MDA concentrations are expressed as millimoles per gram of tissue. 
3.9. Gastric Acid Secretion 
The technique described in Shay et al. (1945) [46] was utilized in the current study. Firstly, pylorus 
ligature was performed under inhalation anesthesia. Then saline and PLS (30 mg·kg
−1) were injected 
intraperitoneally. In another group, gastric acid secretion in pylorus-ligated mice induced by histamine 
(5 mg·kg
−1) or ranitidine (5 mg·kg
−1)  via  i.p.  injection  was tested. After 4 h, the animals were 
sacrificed by deep inhalatory anesthesia, their stomachs were opened, and the gastric content collected. 
The final volume and pH were directly determined after washing the mucosal side of the stomach with 
2  mL  of  distilled water. Total acidity of the gastric juice was titrated with NaOH 0.01  N, using   
2% phenolphthalein as an indicator.  
3.10. Statistical Analysis 
All values are expressed as mean ± SEM. ANOVA and the Student-Newman-Keuls test were used 
to determine  the statistical significance of the differences between the groups. For histological 
assessment, the Kruskal-Wallis nonparametric test was used, followed by Dunn’s test for multiple 
comparisons. Differences were considered to be significant when p < 0.05. 
4. Conclusions 
In conclusion, our results indicate that PLS has a potential gastroprotective effect against   
ethanol-induced gastrophathy. In addition, the mechanism of PLS-mediated protection may be related 
to decreases in free radical production and lipid peroxidation.  Mar. Drugs 2011, 9  2197 
 
Although there are many mechanisms through which this gastroprotective effect could occur, our 
data support the hypothesis that NO and the activation of KATP channels are of primary importance. 
These observations also raise the possibility of PLS  being used to improve resistance to gastric 
mucosal injury. 
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